- Home
- TWIN vs PRQR Comparison
TWIN vs PRQR Comparison
Compare TWIN & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWIN | PRQR |
|---|---|---|
| Founded | 1918 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.5M | 250.7M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | TWIN | PRQR |
|---|---|---|
| Price | $15.60 | $2.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $12.00 | $8.14 |
| AVG Volume (30 Days) | 35.7K | ★ 348.1K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.03% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $347,837,000.00 | $18,859,556.00 |
| Revenue This Year | $10.79 | N/A |
| Revenue Next Year | $8.43 | N/A |
| P/E Ratio | $633.81 | ★ N/A |
| Revenue Growth | ★ 14.24 | N/A |
| 52 Week Low | $6.16 | $1.07 |
| 52 Week High | $17.08 | $3.97 |
Technical Indicators
Market Signals| Indicator | TWIN | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 53.26 |
| Support Level | $14.67 | $2.10 |
| Resistance Level | $15.70 | $2.40 |
| Average True Range (ATR) | 0.58 | 0.17 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 54.02 | 89.49 |
Price Performance
Historical ComparisonAbout TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.